Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17146178rdf:typepubmed:Citationlld:pubmed
pubmed-article:17146178lifeskim:mentionsumls-concept:C0015766lld:lifeskim
pubmed-article:17146178lifeskim:mentionsumls-concept:C0325089lld:lifeskim
pubmed-article:17146178lifeskim:mentionsumls-concept:C0475463lld:lifeskim
pubmed-article:17146178lifeskim:mentionsumls-concept:C0680536lld:lifeskim
pubmed-article:17146178lifeskim:mentionsumls-concept:C1514218lld:lifeskim
pubmed-article:17146178pubmed:issue11lld:pubmed
pubmed-article:17146178pubmed:dateCreated2006-12-5lld:pubmed
pubmed-article:17146178pubmed:abstractTextThe virus neutralization (VN) antibody titers of serum samples from 18 individuals representing 8 carnivore species vaccinated with commercial polyvalent vaccines optimized for domestic cats containing inactivated feline panleukopenia virus (FPLV) were evaluated against canine parvovirus type 2 (CPV2). In addition, the titers among 5 individuals from 4 carnivore were evaluated against antigenic variants of feline parvoviruses; FPLV, CPV2, CPV2a, CPV2b, CPV2c, mink enteritis virus type 1 (MEV1) and MEV2. The polyvalent vaccines induced cross-reactive VN titers against antigenic variants of feline parvoviruses in nondomestic felids. However, we observed very low cross-reactive VN antibody in lions and Siberian tigers, therefore we should pay attention to CPV infections in these animals even if they were vaccinated with inactivated FPLV vaccines.lld:pubmed
pubmed-article:17146178pubmed:languageenglld:pubmed
pubmed-article:17146178pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17146178pubmed:citationSubsetIMlld:pubmed
pubmed-article:17146178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17146178pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17146178pubmed:statusMEDLINElld:pubmed
pubmed-article:17146178pubmed:monthNovlld:pubmed
pubmed-article:17146178pubmed:issn0916-7250lld:pubmed
pubmed-article:17146178pubmed:authorpubmed-author:MiyazawaTakay...lld:pubmed
pubmed-article:17146178pubmed:authorpubmed-author:FukuiDaisukeDlld:pubmed
pubmed-article:17146178pubmed:authorpubmed-author:TakeshiKouich...lld:pubmed
pubmed-article:17146178pubmed:authorpubmed-author:SassaYukikoYlld:pubmed
pubmed-article:17146178pubmed:issnTypePrintlld:pubmed
pubmed-article:17146178pubmed:volume68lld:pubmed
pubmed-article:17146178pubmed:ownerNLMlld:pubmed
pubmed-article:17146178pubmed:authorsCompleteYlld:pubmed
pubmed-article:17146178pubmed:pagination1195-8lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:meshHeadingpubmed-meshheading:17146178...lld:pubmed
pubmed-article:17146178pubmed:year2006lld:pubmed
pubmed-article:17146178pubmed:articleTitleNeutralizing antibodies against feline parvoviruses in nondomestic felids inoculated with commercial inactivated polyvalent vaccines.lld:pubmed
pubmed-article:17146178pubmed:affiliationLaboratory of Veterinary Infectious Diseases, Department of Applied Veterinary Medicine, Obihiro University of Agriculture and Veterinary Medicine, Hokkaido, Japan.lld:pubmed
pubmed-article:17146178pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17146178pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17146178lld:pubmed